Retrospective Review of a Rejuvenation

Program in the Management of

Cancer

Victor A. Marcial-Vega, MDwww.marcialvegamd.com

San Juan, Puerto RicoApril 2013

Presentation Overview

Patient Population Treatment Protocol Results Conclusions

Patient PopulationMay 1998 to February 2001

48 Cancer patients8 Patients Excluded from analysis

Evaluation of 40 patients

Patients excluded from analysis

7 patients less than 5 days of treatment

1 patient had chemotherapy

Total 8 patients

0

1

2

3

4

5

6

7

chem

o

<1

wee

k

Patient Population40 Cancer Patients33 Stage 4(2 had AIDS)

3 Unbiopsied patients

Patient Population40 Patients

1 Stage 1 Ewing’s Sarcoma

1 Stage 3 Squamous Neck

1 Stage 2 Breast1 Stage 1B Hodgkin’s

Patient Population

Six patients failed conventional therapy chemotherapy, radiation or surgery

All had progressive disease No patient was on concomitant

chemotherapy, surgery or radiation

Baseline Studies

Symptoms described by the patients

Present or Absent(1 or 2)

Treatment response(%)

Baseline StudiesCBC, chemistry panelTumor markers(CEA, serotonin)

CAT or MRI scans of tumor

Direct tumor measurements

Baseline StudiesHigh Resolution Blood Imaging indicates:

Free radical activityParasites, bacteria, fungipH

HRBI Setup

Treatment Program

Initial Program 5 days a week/ 3 weeks

Optional-Maintenance Program 5 days a week/1 week monthly

EnvironmentAromatherapyMusicRemoving shoes or surgical booties over shoes

House environment

Treatment Protocol

Nutritional Supplementation Intravenous Vitamin C (+ or

- EDTA) Ozone/Hyperthermia

showers

Treatment Protocol

Hydromassage(daily 30 min)

Massage Therapy(1 hr 2x week)

Respiratory Biofeedback(30 min. daily)

Biofeedback

Treatment Protocol

Steambath/aromatherapy

Observation(Meditation) and Prayer

Daily monitoring by physician

Steambath

Treatment Protocol

Exercises to develop a practice of stillness, relaxation and focus

Use of books, videos, music,counseling

Intravenous Therapy

Vitamin C 20 grams Vitamins B1, B6(100 mg),

B12 (1000ug) Sterile water(250 cc) EDTA 2-6 cc(3g/21cc)

Intravenous Therapy

Three times a week 20 gram weekly increases

until 70 grams or tolerance is reached

Dose range 50-70 grams

Treatment Protocol

All components of the program promote being still and quiet.

All components of the program provide an opportunity for meditation and prayer

Ozone/Hyperthermia

Showers5 days a week1/2 hour treatments98-103 degrees Fahrenheit

ResultsAge Range 8-80 years Median 56 years

Median Follow-up 18 months

Analysis on 40 patients

Patient Subgroups

(A) 33 completed 3 weeks of protocol

(B) 5 completed 1 week (C) 2 had no ozone/hyperthermia

Survival 33/40 alive at time of

report(2002)(83%) Alive and well or recuperating (A) 19/33 = 57% (B) 2/5 = 40% (C) 0/2 = 0% Total 21/40= 53%

Initial Response More than 50%

response Within 3 weeks (A) 25/33= 76% (B) 3/5 = 60% (C) 1/2 = 50% Overall = 72%

01020304050607080

3 w

eeks

1 w

eek

no o

zone

percent

18 months results No tumor after

multiple recurrences 2/33

Complete Response 6/33

Partial 6/33 Total 14/33=42% 0

51015202530354045

no t

um

CR

PR

tota

l

Percent

Symptoms Improvement in 80% first 2 weeks

Sustained at 5 months in 50%

RESULTSSymptoms always precede tumor response

Initial improvement seen first in sleep, energy level, emotional well being

ResultsAll patients that respond start looking and feeling better

Protocol is rejuvenating

Side Effects 2 patients- vitamin C

caused malaise. Resolved in 10 minutes after stopping infusion

1 patient- chills from infected catheter

1 patient- skin pimples

Prognosticators Not worrying A feeling of certainty this

program is for them Ambulatory and able to

take care of self Patients always get worse

when these factors are not present

PrognosticatorsTravel time less than 35 minutes 80% response

Travel time more than 35 minutes 20% response

PrognosticatorsThe addition of ozone/hyperthermia has improved our results from an initial response of 20% in stage 4 cancer to 79%

ConclusionsRejuvenation Program will yield an initial response rate of 79% in stage 4 cancer

18 month response is 36%

ConclusionsResponse needs to be measured with symptoms as well as tumor regression since these always precede physical signs of response

Conclusions Survival is 53% CR in 6/33 patients=18% 2/2 AIDS related cancers in

complete remission 1 CR Stage 3 lymphoma 1 CR recurrent T4 SCC RMT 1 CR Multiple Myeloma 1CR Endometrial CA Stage 4

Future DirectionsDevelop a physician network in the world that will use ozone/hyperthermia

Add the use of colonicsContinuing beyond 3 weeks

Future DirectionsStart managing stage 1 and 2 cancer patients with an integrated non-toxic program

Implement as part of anti-aging programs worldwide

Mind-Body-Spirit Counseling